Turning Point Brands (TPB) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 May, 2026Opening remarks and agenda
Meeting opened by Senior Vice President, General Counsel, and Secretary, with introductions of all board members and key management present.
Independent auditors from KPMG LLP and inspectors of election were introduced.
Confirmation of proper notice to stockholders and availability of the certified list of stockholders for inspection.
Quorum confirmed and meeting declared properly constituted for business.
Board and executive committee updates
Board members and committee chairs, including Audit, Nominating and Governance, and Compensation and Talent Committees, were introduced.
Senior management team members, including CFO and Chief Growth Officer, were present.
Corporate governance
Inspectors of election sworn in and tasked with overseeing voting and reporting results.
Voting procedures for shareholders explained, including proxy and electronic voting.
Latest events from Turning Point Brands
- Modern Oral sales soared 128% YoY, boosting revenue but profits fell on higher investment.TPB
Q2 2026 - Modern Oral net sales jumped 133%, driving Q1 growth and higher FY 2026 guidance.TPB
Q1 2026 - Annual meeting to vote on directors, auditor, and executive pay, with emphasis on diversity and governance.TPB
Proxy filing - Modern Oral net sales jumped 266% in Q4, fueling 29% revenue growth and a strong 2026 outlook.TPB
Q4 2025 - Board recommends voting for all proposals, emphasizing diversity and governance improvements.TPB
Proxy Filing - Key votes include director elections, auditor change, officer liability limits, and executive pay approval.TPB
Proxy Filing - Q3 2024 saw double-digit profit growth, raised guidance, and expanded share buybacks.TPB
Q3 2024 - Q2 sales and EBITDA rose, guidance increased, and net income jumped 31% on strong segment growth.TPB
Q2 2024 - FY2024 net sales up 11% and EBITDA up 12%, with strong modern oral and core brand growth.TPB
Q4 2024